z-logo
Premium
A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine‐associated symptoms: A post hoc analysis
Author(s) -
Cohen Fred,
Friedman Benjamin W.
Publication year - 2021
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/head.14185
Subject(s) - prochlorperazine , phonophobia , medicine , hydromorphone , anesthesia , migraine , nausea , photophobia , sumatriptan , diphenhydramine , aura , surgery , opioid , receptor , histamine , agonist
We conducted a randomized trial among emergency department patients with migraine to determine the relative impact on migraine-associated symptoms of hydromorphone, an opioid, versus prochlorperazine, an antidopaminergic antiemetic.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom